Literature DB >> 24821150

Outcome of patients with acute kidney injury in severe sepsis and septic shock treated with early goal-directed therapy in an intensive care unit.

Wasim Ahmed1, Javed I Memon, Rifat Rehmani, Abdulmajeed Al Juhaiman.   

Abstract

Acute kidney injury (AKI) in the intensive care unit (ICU) is commonly caused by severe sepsis and septic shock. There is limited data regarding the incidence and outcomes of patients developing AKI treated with early goal-directed therapy (EGDT). Our aim was to observe the incidence and outcomes of patients with AKI in severe sepsis and septic shock, treated with EGDT as compared with historic controls. Study subjects included all adults admitted to the ICU with a diagnosis of severe sepsis and septic shock prior to (historic controls) and after introduction of EGDT (intervention group). Two groups were compared for incidence of AKI, length of ICU and hospital stay, incidence and requirement for renal replacement therapy, serum creatinine at discharge, maximum RIFLE (Risk, injury, failure, loss, end stage) in each group and 28-day mortality. Two groups were well matched for age, sex, (April 16, 2014) and acute physiological and chronic health evaluation (APACHE) II scores. We found no significant difference in the incidence of AKI (51% vs. 46%). There was no statistical difference in any of the above outcomes, including 28-day mortality in historic controls versus patients treated with EGDT. Septic AKI is a complex syndrome. The incidence and outcomes have not improved despite advances in sepsis management and EGDT. Very early detection of septic AKI and targeted therapies may improve outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821150     DOI: 10.4103/1319-2442.132171

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  8 in total

Review 1.  Clinical approach to the patient with AKI and sepsis.

Authors:  Mélanie Godin; Patrick Murray; Ravindra L Mehta
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

2.  Effect of goal-directed fluid therapy on renal function in critically ill patients: a systematic review and meta-analysis.

Authors:  Cong-Cong Zhao; Yan Ye; Zhi-Qiang Li; Xin-Hui Wu; Chai Zhao; Zhen-Jie Hu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Goal-directed therapy: what we know and what we need to know.

Authors:  Jason B O'Neal; Andrew D Shaw
Journal:  Perioper Med (Lond)       Date:  2015-02-05

4.  Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.

Authors:  Patrick M Honore; H Bryant Nguyen; Michelle Gong; Lakhmir S Chawla; Sean M Bagshaw; Antonio Artigas; Jing Shi; Olivier Joannes-Boyau; Jean-Louis Vincent; John A Kellum
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

Review 5.  Update on sepsis-associated acute kidney injury: emerging targeted therapies.

Authors:  James F Doyle; Lui G Forni
Journal:  Biologics       Date:  2016-11-07

6.  Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: a prospective observational study.

Authors:  Fabien Stucker; Belen Ponte; Victoria De la Fuente; Cyrielle Alves; Olivier Rutschmann; Sebastian Carballo; Nicolas Vuilleumier; Pierre-Yves Martin; Thomas Perneger; Patrick Saudan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

Review 7.  Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney.

Authors:  Xiukai Chen; Xiaoting Wang; Patrick M Honore; Herbert D Spapen; Dawei Liu
Journal:  Ann Intensive Care       Date:  2018-09-20       Impact factor: 6.925

8.  Application strategy of PiCCO in septic shock patients.

Authors:  Xiaoyun Liu; Wenli Ji; Jifeng Wang; Tao Pan
Journal:  Exp Ther Med       Date:  2016-01-29       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.